These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19618661)

  • 1. Short-term cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor-I.
    Mahachoklertwattana P; Wanasuwankul S; Poomthavorn P; Choubtum L; Sriphrapradang A
    J Pediatr Endocrinol Metab; 2009 May; 22(5):425-32. PubMed ID: 19618661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproheptadine is an effective appetite stimulant in cystic fibrosis.
    Homnick DN; Homnick BD; Reeves AJ; Marks JH; Pimentel RS; Bonnema SK
    Pediatr Pulmonol; 2004 Aug; 38(2):129-34. PubMed ID: 15211696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis.
    Epifanio M; Marostica PC; Mattiello R; Feix L; Nejedlo R; Fischer GB; Stein RT
    J Pediatr (Rio J); 2012; 88(2):155-60. PubMed ID: 22544046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis.
    Homnick DN; Marks JH; Hare KL; Bonnema SK
    Pediatr Pulmonol; 2005 Sep; 40(3):251-6. PubMed ID: 16015665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy.
    Kaplowitz PB; Jennings S
    J Pediatr; 1987 Jan; 110(1):140-3. PubMed ID: 3794875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appetite stimulation and weight gain with cyproheptadine. A double-blind study in underweight children.
    Sanzgiri RR; Mohamad HA; Raja Z
    J Postgrad Med; 1970 Jan; 16(1):12-5. PubMed ID: 4913983
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ghrelin concentrations are increased in children with growth hormone insensitivity and decrease during long-term insulinlike growth factor-I treatment.
    Uckun-Kitapci A; Haqq AM; Purnell JQ; Newcomb K; Gulkesen H; Underwood LE
    J Investig Med; 2008 Jan; 56(1):26-31. PubMed ID: 18317425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
    Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
    Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
    Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
    Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyproheptadine in young children with feeding difficulties and poor growth in a pediatric feeding program.
    Sant'Anna AM; Hammes PS; Porporino M; Martel C; Zygmuntowicz C; Ramsay M
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):674-8. PubMed ID: 24941960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
    Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
    Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Tolerability of Cyproheptadine in Poor Appetite: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
    Kim SY; Yun JM; Lee JW; Cho YG; Cho KH; Park YG; Cho B
    Clin Ther; 2021 Oct; 43(10):1757-1772. PubMed ID: 34509304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review.
    Harrison ME; Norris ML; Robinson A; Spettigue W; Morrissey M; Isserlin L
    Appetite; 2019 Jun; 137():62-72. PubMed ID: 30825493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.